Kolexia
Goudemand Jenny Médecine générale
Goudemand Jenny
Médecine générale
Institut Coeur Poumon Chu Lille
Lille, France
128 Activités
33 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Maladies de von Willebrand Hémophilie A Hémorragie Maladie de von Willebrand de type 1 Maladie de von Willebrand de type 3 Maladie de von Willebrand de type 2 Hémophilie B Déficit en facteur XI Angiodysplasie

Collaborateurs

Voir plus
Susen Sophie
Susen Sophie
Centre de Biologie - Pathologie, Lille, France
Rauch Antoine
Rauch Antoine
Centre de Biologie - Pathologie, Lille, France
Borel-Derlon Annie
Borel-Derlon Annie
Hôpital Côte de Nacre, Caen, France
Trossaert Marc
Trossaert Marc
Hôpital Hôtel-Dieu Nantes, Nantes, France

Industries

Voir plus
LFB
23 collaboration(s)
Dernière en 2023
B3TSI
4 collaboration(s)
Dernière en 2021
EXAFIELD
2 collaboration(s)
Dernière en 2020
Takeda Pharmaceutical
1 collaboration(s)
Dernière en 2021

Dernières activités

Voir plus
von Willebrand factor: aging is better?
Journal of thrombosis and haemostasis : JTH   27 novembre 2023
Colon cancer surgery in von Willebrand disease type 3 setting triggering vascular abnormalities on bowel anastomosis.
Research and practice in thrombosis and haemostasis   10 juin 2023
TRANSHEMO: Determinants and Consequences of the Transition to Adulthood Among Adolescents With Haemophilia - TRANSHEMO
Essai Clinique (Assistance publique - Hôpitaux de Marseille)   13 février 2023
PO221 TREATMENT WITH A PLASMA-DERIVED VON WILLEBRAND FACTOR (VWF) ALMOST DEVOID OF FACTOR VIII IN PAEDIATRIC PATIENTS WITH VON WILLEBRAND DISEASE (VWD): A POOLED ANALYSIS
16th Annual Congress of European Association for Haemophilia and Allied Disorders 2023, 7–10 February 2023, Manchester   05 février 2023
von Willebrand factor neutralizing and non-neutralizing alloantibodies in 213 subjects with type 3 von Willebrand disease enrolled in 3WINTERS-IPS.
Journal of thrombosis and haemostasis : JTH   11 janvier 2023
Reinvestigation of unidentified causative variants in FXI-deficient patients: Focus on gene segment deletions.
Haemophilia : the official journal of the World Federation of Hemophilia   04 octobre 2022
The Cost of Von Willebrand Disease in Europe: The CVESS Study.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis   19 août 2022
Identification of von Willebrand factor D4 domain mutations in patients of Afro-Caribbean descent: In vitro characterization.
Research and practice in thrombosis and haemostasis   15 juin 2022
Efficacy and safety of von Willebrand factor concentrate almost devoid of factor VIII (Wilfactin ) in paediatric patients under 6 years of age with severe von Willebrand disease.
Blood transfusion = Trasfusione del sangue   19 avril 2022
Von Willebrand factor propeptide and pathophysiological mechanisms in European and Iranian patients with type 3 von Willebrand disease enrolled in the 3WINTERS-IPS study.
Journal of thrombosis and haemostasis : JTH   22 février 2022